Potential Therapies to Protect the Aging Heart Against Ischemia/Reperfusion Injury
Open Access
- 19 November 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Abstract
Despite important advances in the treatment of myocardial infarction that have significantly reduced mortality, there is still an unmet need to limit the infarct size after reperfusion injury in order to prevent the onset and severity of heart failure. Multiple cardioprotective maneuvers, therapeutic targets, peptides and drugs have been developed to effectively protect the myocardium from reperfusion-induced cell death in preclinical studies. Nonetheless, the translation of these therapies from laboratory to clinical contexts has been quite challenging. Comorbidities, comedications or inadequate ischemia/reperfusion experimental models are clearly identified variables that need to be accounted for in order to achieve effective cardioprotection studies. The aging heart is characterized by altered proteostasis, DNA instability, epigenetic changes, among others. A vast number of studies has shown that multiple therapeutic strategies, such as ischemic conditioning phenomena and protective drugs are unable to protect the aged heart from myocardial infarction. In this Mini-Review, we will provide an updated state of the art concerning potential new cardioprotective strategies targeting the aging heart.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico
This publication has 73 references indexed in Scilit:
- The Inflammasome in Myocardial Injury and Cardiac RemodelingAntioxidants & Redox Signaling, 2015
- Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarctionNature Communications, 2014
- Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote ConditioningPharmacological Reviews, 2014
- Advanced Age Impairs Cardioprotective Function of Mesenchymal Stem Cell Transplantation from Patients to Myocardially Infarcted RatsCardiology, 2014
- Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and TransformationCancer Research, 2013
- Telomeres and Mitochondria in the Aging HeartCirculation Research, 2012
- Health perspectives: International epidemiology of ageingBest Practice & Research Clinical Anaesthesiology, 2011
- The Aging Heart and Post-Infarction Left Ventricular RemodelingJACC, 2011
- Sterile inflammation: sensing and reacting to damageNature Reviews Immunology, 2010
- Reversal of mitochondrial defects before ischemia protects the aged heartThe FASEB Journal, 2006